Skip to content

Author

Muhindo Edgar

1 paper indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Jul 2026

Nanotechnology-Enabled Reprogramming of the Tumor Microenvironment: Targeting Cancer-Associated Fibroblasts and Immune Suppression

This review critically examines recent advances in nanotechnology-enabled targeting of CAFs and immune suppression within the TME, and concludes that nanotechnology-driven TME modulation represents a promising paradigm shift toward more durable and effective cancer therapies.

Muhindo Edgar · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.